288 related articles for article (PubMed ID: 28665620)
1. Multifunctional Desferrichrome Analogues as Versatile
Adams CJ; Wilson JJ; Boros E
Mol Pharm; 2017 Aug; 14(8):2831-2842. PubMed ID: 28665620
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
3. Linear Desferrichrome-Linked Silicon-Rhodamine Antibody Conjugate Enables Targeted Multimodal Imaging of HER2 in Vitro and in Vivo.
Ahn SH; Thach D; Vaughn BA; Alford VM; Preston AN; Laughlin ST; Boros E
Mol Pharm; 2019 Mar; 16(3):1412-1420. PubMed ID: 30714739
[TBL] [Abstract][Full Text] [Related]
4. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
[TBL] [Abstract][Full Text] [Related]
5. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.
Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ
Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for
Raavé R; Sandker G; Adumeau P; Jacobsen CB; Mangin F; Meyer M; Moreau M; Bernhard C; Da Costa L; Dubois A; Goncalves V; Gustafsson M; Rijpkema M; Boerman O; Chambron JC; Heskamp S; Denat F
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1966-1977. PubMed ID: 31161258
[TBL] [Abstract][Full Text] [Related]
7. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.
Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW
Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.
Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW
Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446
[TBL] [Abstract][Full Text] [Related]
9. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
[TBL] [Abstract][Full Text] [Related]
10. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab-conjugated oxine-based ligand for [
Southcott L; Wharton L; Rousseau J; Merkens H; Yang H; Bénard F; Orvig C
J Inorg Biochem; 2022 Oct; 235():111936. PubMed ID: 35878576
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Modular Desferrioxamine Analogues and Evaluation of Zwitterionic Derivatives for Zirconium Complexation.
Outzen L; Münzmay M; Frangioni JV; Maison W
ChemMedChem; 2023 Jul; 18(13):e202300112. PubMed ID: 37057615
[TBL] [Abstract][Full Text] [Related]
13. Cyclic versus Noncyclic Chelating Scaffold for
Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C
Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082
[TBL] [Abstract][Full Text] [Related]
14. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of new bifunctional
Klasen B; Lemcke D; Mindt TL; Gasser G; Rösch F
Nucl Med Biol; 2021; 102-103():12-23. PubMed ID: 34242949
[TBL] [Abstract][Full Text] [Related]
17. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
[TBL] [Abstract][Full Text] [Related]
18. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
Guérard F; Lee YS; Brechbiel MW
Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
[TBL] [Abstract][Full Text] [Related]
19. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical
Chomet M; Schreurs M; Bolijn MJ; Verlaan M; Beaino W; Brown K; Poot AJ; Windhorst AD; Gill H; Marik J; Williams S; Cowell J; Gasser G; Mindt TL; van Dongen GAMS; Vugts DJ
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):694-707. PubMed ID: 32889615
[TBL] [Abstract][Full Text] [Related]
20. Bioorthogonal Fluorophore Linked DFO-Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies.
Meimetis LG; Boros E; Carlson JC; Ran C; Caravan P; Weissleder R
Bioconjug Chem; 2016 Jan; 27(1):257-63. PubMed ID: 26684717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
